Skip to main content
. Author manuscript; available in PMC: 2009 Apr 10.
Published in final edited form as: Cancer Biomark. 2005;1(4-5):241–250. doi: 10.3233/cbm-2005-14-507

Fig. 2.

Fig. 2

Kaplan-Meier curves and log-rank tests to assess the risk of recurrence based on the Bcl-2 expression status and tumor stage in Caucasians with CRCs: Significant difference in rate of recurrence was observed between stage II and stage III CRC cases (A). Deceased or lack of Bcl-2 expression was significantly associated with an increased rate of recurrence only in patients with stage II (B) but not in Stage III (C) CRCs.